Impax Asset Management Group’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17M	Hold	750,027	–	–	0.12%	108
2025 Q4	$19.4M	Buy	750,027 +150,000	+25%	+$3.57M	0.12%	107
2025 Q3	$15.5M	Buy	600,027 +130,000	+28%	+$3.19M	0.09%	116
2025 Q2	$11.2M	Sell	470,027 -70,000	-13%	-$1.76M	0.06%	131
2025 Q1	$13.4M	Hold	540,027	–	–	0.08%	124
2024 Q4	$10.2M	Buy	540,027 +69,424	+15%	+$1.22M	0.05%	159
2024 Q3	$7.08M	Buy	470,603 +210,576	+81%	+$3.6M	0.03%	198
2024 Q2	$7.44M	Hold	260,027	–	–	0.03%	186
2024 Q1	$7.6M	Buy	260,027 +60,000	+30%	+$1.84M	0.03%	196
2023 Q4	$6.75M	Hold	200,027	–	–	0.03%	197
2023 Q3	$6.14M	Hold	200,027	–	–	0.03%	194
2023 Q2	$8.02M	Hold	200,027	–	–	0.03%	179
2023 Q1	$8.16M	Hold	200,027	–	–	0.03%	170
2022 Q4	$7.72M	Sell	200,027 -70,000	-26%	-$3.41M	0.03%	168
2022 Q3	$14.4M	Hold	270,027	–	–	0.07%	131
2022 Q2	$15.7M	Sell	270,027 -15,000	-5%	-$983K	0.08%	128
2022 Q1	$21.8M	Buy	285,027 +26,091	+10%	+$1.74M	0.09%	121
2021 Q4	$15.6M	Buy	258,936 +58,909	+29%	+$3.25M	0.06%	135
2021 Q3	$11.2M	Buy	200,027 +30,000	+18%	+$1.73M	0.05%	147
2021 Q2	$10.3M	Buy	170,027 +45,027	+36%	+$2.85M	0.05%	153
2021 Q1	$8.76M	Buy	+125,000	New	+$8.93M	0.04%	149